Search research articles
Contact Us
Filters
Showing results (81-90 of 194) with videos related to
Page
of 20
Sort By:
Clinical Toxicology (Philadelphia, Pa.)
|
December 15, 2011
Case series of selenium toxicity from a nutritional supplement
Barrak M Aldosary, Mark E Sutter, Michael Schwartz, et al.
Neuroreport
|
May 9, 2002
Darkness beyond the light: attentional inhibition surrounding the classic spotlight
Scott D Slotnick, Joseph B Hopfinger, Stanley A Klein, et al.
International Journal of Emergency Medicine
|
October 14, 2011
Gastrointestinal decontamination in the acutely poisoned patient
Timothy E Albertson, Kelly P Owen, Mark E Sutter, et al.
FP Essentials
|
February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs
Timothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs
|
December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthma
Timothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
FP Essentials
|
February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs
Timothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Clinical and Experimental Emergency Medicine
|
February 8, 2017
Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathy
Deborah B Diercks, Kelly P Owen, Jeffrey A Kline, et al.
Visual Neuroscience
|
September 1, 1994
Retinotopic and nonretinotopic field potentials in cat visual cortex
M Kitano, K Niiyama, T Kasamatsu, et al.
Veterinary Microbiology
|
February 14, 2009
Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets
J Miclard, M Jäggi, E Sutter, et al.
Clinical Reviews in Allergy & Immunology
|
May 8, 2013
Volatile substance misuse: an updated review of toxicity and treatment
Jonathan B Ford, Mark E Sutter, Kelly P Owen, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 194) with videos related to
Sort By:
Page
of 20
Clinical Toxicology (Philadelphia, Pa.)
|
December 15, 2011
Case series of selenium toxicity from a nutritional supplement
Barrak M Aldosary, Mark E Sutter, Michael Schwartz, et al.
Neuroreport
|
May 9, 2002
Darkness beyond the light: attentional inhibition surrounding the classic spotlight
Scott D Slotnick, Joseph B Hopfinger, Stanley A Klein, et al.
International Journal of Emergency Medicine
|
October 14, 2011
Gastrointestinal decontamination in the acutely poisoned patient
Timothy E Albertson, Kelly P Owen, Mark E Sutter, et al.
FP Essentials
|
February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal Highs
Timothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs
|
December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthma
Timothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
FP Essentials
|
February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing Drugs
Timothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Clinical and Experimental Emergency Medicine
|
February 8, 2017
Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathy
Deborah B Diercks, Kelly P Owen, Jeffrey A Kline, et al.
Visual Neuroscience
|
September 1, 1994
Retinotopic and nonretinotopic field potentials in cat visual cortex
M Kitano, K Niiyama, T Kasamatsu, et al.
Veterinary Microbiology
|
February 14, 2009
Clostridium perfringens beta-toxin targets endothelial cells in necrotizing enteritis in piglets
J Miclard, M Jäggi, E Sutter, et al.
Clinical Reviews in Allergy & Immunology
|
May 8, 2013
Volatile substance misuse: an updated review of toxicity and treatment
Jonathan B Ford, Mark E Sutter, Kelly P Owen, et al.
Page
of 20